It was revealed on Wednesday that HHS is recommending that the Drug Enforcement Agency move marijuana from a Schedule I-listed drug to Schedule III under the Controlled Substances Act. The move would be a boon for marijuana companies who have been pushing for marijuana to be delisted or at least downgraded, and their stock performance is reflecting that.
“For just the industry it’s a tremendous deal,” Baruchowitz told the Washington Examiner in a Thursday interview. He noted that it is the first time that an executive-level agency has recommended that there be a fundamental and permanent change to U.S. cannabis rules. The recommendation comes after President Joe Biden ordered a comprehensive review of available marijuana research to assess whether there should be any scheduling changes. Biden at the time also granted a pardon to all people who were federally convicted of simple marijuana possession.
While once illegal in all 50 states and at the federal level, marijuana has become more accepted for both medical and recreational use. There has been a growing mismatch between federal and state drug policy — 37 states and the District of Columbia have legalized medical marijuana. Twenty-three states have gone even further and legalized the drug for adult use.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
La source: FoxBusiness - 🏆 458. / 53 Lire la suite »
La source: MarketWatch - 🏆 3. / 97 Lire la suite »
La source: NBCLA - 🏆 319. / 59 Lire la suite »
La source: denverpost - 🏆 13. / 72 Lire la suite »